MyFinsight
Home
Blog
About
Contact
Download
Download image
Income taxes
$9,149K
Proceeds from maturities
of marketable...
$10,150K
Net loss for the
period
$3,258K
Other current
receivables
-$1,463K
Share-based compensation
expense
$1,409K
Impairment loss on rou asset
$330K
Non-cash lease expense
$299K
Depreciation expense
$72K
Foreign exchange gain
-$39K
Proceeds from issuance of
common stock under the...
$30K
Net cash used in
operating activities
$2,651K
Net cash provided by
investing activities
$2,537K
Canceled cashflow
$13,368K
Net cash provided by
financing activities
$30K
Canceled cashflow
$7,613K
Net decrease in cash
and cash...
$5,169K
Canceled cashflow
$49K
Gain on termination
of collaboration...
$3,257K
something is missing
-$3,257K
Accounts payable
-$2,667K
Accrued expenses and
other current...
-$2,223K
Prepaid expenses
$1,052K
Net accretion of
marketable securities
$480K
Operating lease
liability, current portion
-$302K
Gain on sale of
technology and other assets
$130K
Purchase of marketable
securities
$7,613K
Effect of exchange rate
fluctuations on cash held
-$49K
Back
Back
Cash Flow
source: myfinsight.com
Repare Therapeutics Inc. (RPTX)
Repare Therapeutics Inc. (RPTX)